Breath Therapeutics’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Breath Therapeutics is a biopharmaceutical company that develops inhalation therapies for severe respiratory diseases. Read more

Breath Therapeutics is a biopharmaceutical company that develops inhalation therapies for severe respiratory diseases. Read more

Jens Stegemann's photo - Co-Founder & CEO of Breath Therapeutics

Co-Founder & CEO

Jens Stegemann

CEO Approval Rating

90/100

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Synairgen is seen as one of Breath Therapeutics's top competitors. Synairgen was founded in 2003, and is headquartered in Southampton, England. Like Breath Therapeutics, Synairgen also competes in the Pharmaceuticals industry. Synairgen generates $3.3M more revenue vs. Breath Therapeutics.

Verona Pharma is a top competitor of Breath Therapeutics. Verona Pharma was founded in 2005, and its headquarters is in London, England. Like Breath Therapeutics, Verona Pharma also competes in the Biotechnology field. Verona Pharma has 32 fewer employees than Breath Therapeutics.

Enterprise Therapeutics is Breath Therapeutics's #3 rival. Enterprise Therapeutics was founded in Brighton, England} in 2014. Like Breath Therapeutics, Enterprise Therapeutics also works within the Pharmaceuticals industry. Compared to Breath Therapeutics, Enterprise Therapeutics generates $4.8M more revenue.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Medexus Pharma, Inc. a competitor of Breath Therapeutics?

Acquisitions

No recent acquisitions found related to Breath Therapeutics

Breath Therapeutics Funding History

$48.6M

Since Breath Therapeutics was founded in 2016, it has participated in 1 round of funding. In total Breath Therapeutics has raised $48.6M. Breath Therapeutics' funding round was on Mar 2017 for a total of $48.6M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Series A
Mar 2017
$48.6M

GIMV

Since Breath Therapeutics was founded in 2016, it has participated in 1 round of funding. In total Breath Therapeutics has raised $48.6M. Breath Therapeutics' funding round was on Mar 2017 for a total of $48.6M

Investments

No recent investments found related to Breath Therapeutics

Breath Therapeutics News

July 25, 2019FinSMEs

Zambon Acquires Breath Therapeutics, For Up To €500M

Zambon, an Italian multinational pharmaceutical company, acquired Breath Therapeutics, a biopharmaceu... See more »

Breath Therapeutics Videos

March 7, 2019Breath Therapeutics Vimeo Channel

"Hear experts discuss their clinical experience with BOS" on VIMEO

Ramsey Hachem, MD, Shambu Aryal, MD, Marie Budev, MD, and Selim M. Arcasoy, MD discuss bronchiolitis ... See more »

Social Media

Headquarters

Aldringenstrabe 4 2nd Floor

Munich, Bavaria80639

49-89-9042-149-10

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Breath Therapeutics is a biopharmaceutical company that develops inhalation therapies for severe respiratory diseases. Breath Therapeutics was founded in 2016. Breath Therapeutics' headquarters is located in Munich, Bavaria, DE 80639. It has raised 48...

CEO

Breath Therapeutics's Co-Founder & CEO, Jens Stegemann, currently has an approval rating of 90%. Breath Therapeutics's primary competitors are Synairgen, Verona Pharma & Enterprise Therapeutics.

Website

breath-therapeutics.com

Frequently Asked Questions about Breath Therapeutics

  1. When was Breath Therapeutics founded?

    Breath Therapeutics was founded in 2016
  2. Who is Breath Therapeutics's CEO?

    Breath Therapeutics's CEO is Jens Stegemann
  3. How much revenue does Breath Therapeutics generate?

    Breath Therapeutics generates $3M in revenue
  4. How much funding does Breath Therapeutics have?

    Breath Therapeutics has historically raised $48.6M in funding
  1. Where is Breath Therapeutics's headquarters?

    Breath Therapeutics's headquarters is in Munich Bavaria, DE
  2. How many employees does Breath Therapeutics have?

    Breath Therapeutics has 57 employees
  3. What sector does Breath Therapeutics operate in?

    Breath Therapeutics is in Biotechnology, Pharmaceuticals
  4. Who are Breath Therapeutics's competitors?

    Breath Therapeutics's top competitors are Synairgen, Verona Pharma, Enterprise Therapeutics